
BIOVF
Healthcare · Drug Manufacturers - Specialty & Generic · $17.77B market cap
$51.050.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 27, 2026 | After the close | 6.12 | 0.69 | -88.7% |
| Jul 16, 2026 | After the close | 3.22 | 0.33 | -89.6% |
| Apr 28, 2026 | After the close | 3.56 | 0.41 | -88.4% |
| Oct 20, 2025 | After the close | 4.99 | -0.88 | -117.7% |
| Jul 16, 2025 | After the close | 1.62 | 0.19 | -88.3% |
| Apr 29, 2025 | Before the open | — | 0.24 | — |
| Feb 5, 2025 | Before the open | — | 0.37 | — |
| Oct 24, 2024 | Before the open | — | 0.41 | — |
| Jul 16, 2024 | Before the open | — | 0.06 | — |
| Apr 25, 2024 | Before the open | — | 0.22 | — |
| Feb 8, 2024 | Before the open | — | 0.28 | — |
| Feb 7, 2023 | After the close | 4.63 | 4.64 | +0.2% |
| Oct 26, 2022 | After the close | 1.33 | 1.59 | +19.5% |
Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. The company operates through three segments: Haematology, Immunology, and Specialty Care. It offers Alprolix for haemophilia B; ALTUVOCT for the treatment and prophylaxis of bleeding in patients with haemophilia A;…
| Jul 18, 2022 |
| After the close |
| 0.62 |
| 0.86 |
| +38.7% |
| Apr 27, 2022 | After the close | 2.81 | 3.64 | +29.5% |
| Feb 9, 2022 | After the close | 3.41 | 4.18 | +22.6% |
| Oct 21, 2021 | After the close | 1.30 | 1.59 | +22.3% |
| Jul 20, 2021 | After the close | 0.65 | 0.90 | +38.5% |
| May 3, 2021 | After the close | 2.44 | 2.33 | -4.5% |
| Feb 17, 2021 | After the close | 3.02 | 3.69 | +22.2% |
| Oct 21, 2020 | After the close | 1.07 | 0.93 | -13.1% |
| Jul 15, 2020 | After the close | 1.69 | 0.95 | -43.8% |
| Apr 28, 2020 | After the close | 4.31 | 3.98 | -7.7% |
| Feb 12, 2020 | After the close | 5.58 | 4.86 | -12.9% |
| Oct 30, 2019 | After the close | 1.86 | 1.83 | -1.6% |
| Jul 16, 2019 | After the close | 1.65 | 1.69 | +2.4% |
| Apr 24, 2019 | After the close | 3.58 | 3.12 | -12.8% |
| Feb 19, 2019 | After the close | 2.23 | 2.20 | -1.3% |
| Oct 30, 2018 | After the close | 2.48 | 2.30 | -7.3% |
| Jul 17, 2018 | After the close | 1.91 | 2.53 | +32.5% |
| Apr 25, 2018 | After the close | 1.46 | 1.90 | +30.1% |
| Feb 21, 2018 | After the close | 1.15 | 1.32 | +14.8% |